Rapid Micro Biosystems

Rapid Micro Biosystems Financial Leverage

The Financial Leverage (Equity Multiplier) of Rapid Micro Biosystems (RPID) as of Nov 4, 2026 is 2.25. In the previous year, Financial Leverage (Equity Multiplier) was 1.30 — a change of 73.02% (higher).

Financial Leverage

2.25

YoY

73.02%

Last updated:

Financial Leverage (Equity Multiplier) of Rapid Micro Biosystems is 2025 2.25 . Financial Leverage (Equity Multiplier) of Rapid Micro Biosystems was 2024 1.30 . It decreases by 73.02% higher compared to the previous year.

The Rapid Micro Biosystems Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
-43.71 USD
Jan 1, 2020
2.82 USD
Jan 1, 2021
1.09 USD
Jan 1, 2022
1.16 USD
Jan 1, 2023
1.22 USD
Jan 1, 2024
1.30 USD
Jan 1, 2025
2.25 USD
The Rapid Micro Biosystems Financial Leverage history
YEARFinancial LeverageYoY
2.25+73.02%
1.30+7.16%
1.22+4.69%
1.16+6.41%
1.09-61.30%
2.82-106.45%
-43.71—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rapid Micro Biosystems Stock analysis

What does Rapid Micro Biosystems do? Rapid Micro Biosystems Inc is a company specialized in the manufacturing of automated microbiology analysis systems. It was founded in 2006 and is headquartered in Lowell, Massachusetts, USA. The founders aimed to automate microbiology analysis in laboratories to achieve faster and more reliable results. They developed an innovative system that allows for sample analysis within a few hours, with higher accuracy compared to traditional methods. Rapid Micro Biosystems Inc's business model is based on the development and marketing of automated microbiology analysis systems for various industries, including pharmaceutical, medical device, cosmetic, food, and beverage. The company offers products such as the Growth DirectTM microbiology analysis systems that provide advantages in optimizing production processes, reducing time for sample verification, enabling quick detection of errors, and ensuring high quality and reliability. In summary, Rapid Micro Biosystems Inc is an innovative company specializing in the development and marketing of automated microbiology analysis systems. They have gained a significant customer base in different industries and provide solutions and technologies that optimize production processes while meeting the highest quality standards. Rapid Micro Biosystems is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rapid Micro Biosystems stock

Financial Leverage (Equity Multiplier) of Rapid Micro Biosystems is 2.25 in 2025.

Financial Leverage (Equity Multiplier) of Rapid Micro Biosystems changed from 1.30 to 2.25, representing a 73.02% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Rapid Micro Biosystems since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Rapid Micro Biosystems with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Rapid Micro Biosystems

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Rapid Micro Biosystems